Company: TYRA
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001193125-25-085709
Chunk: 55

Company: Tyra Biosciences, Inc.
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 55
---
 gross proceeds of approximately $200.0 million (the 34

“2024 Private Placement”), before deducting offering expenses. The following table sets forth the aggregate number of shares acquired by related persons in the 2024 Private Placement:

| Name of Securityholder                                   |     | Shares of 
 Common    
 Stock     |           |     | Pre-Funded 
 Warrants   |           |     | Aggregate 
 Purchase  
 Price     |               |
|:---------------------------------------------------------|:----|:----------|----------:|:----|:-----------|----------:|:----|:----------|--------------:|
| Entities affiliated with RA Capital Management, L.P. (1) |     |           | 3,180,155 |     |            | 1,538,457 |     | $         | 61,387,603.67 |
| Nextech VI Oncology SCSp (2)                             |     |           | 1,537,279 |     |            |           |     | $         | 19,999,999.79 |
| Entities affiliated with FMR, LLC (3)                    |     |           | 1,430,621 |     |            |           |     | $         | 18,612,379.21 |
| Entities affiliated with BVF Partners L.P. (4)           |     |           | 1,921,599 |     |            |           |     | $         | 25,000,002.99 |
| Entities affiliated with Boxer Capital, LLC (5)          |     |           |    63,412 |     |            |   705,280 |     | $         |  9,999,977.64 |

| (1) | RA Capital Healthcare Fund, L.P. and RA Capital Nexus Fund, L.P. are affiliates of RA Capital, and RA Capital is a holder of 5% or more of our capital stock. Jake Simson, Ph.D. is a Partner at RA Capital and a member of our Board. |

| (2) | Melissa McCracken, Ph.D., who is a member of our Board, is a Principal at Nextech Invest Ltd. (an affiliate of Nextech VI Oncology SCSp). |

| (3) | Entities affiliated with FMR LLC hold 5% or more of our capital stock. |

| (4) | Entities affiliated with BVF Partners L.P. hold 5% or more of our capital stock